Updated July 2026 · 10 min read
Part of the ICU Pharmacology Hub — browse every related guide in one place.
You hang propofol on almost every intubated patient, but understanding why it does what it does — sedates fast, drops the pressure, wakes up quickly, and occasionally turns deadly — is what separates a nurse who runs the drip from a nurse who anticipates it. Here is the mechanism-level picture every ICU nurse and CRNA student should carry.
Propofol's main action is at the GABA-A receptor, the brain's dominant inhibitory chloride channel. Propofol binds at a site distinct from where benzodiazepines bind and potentiates the effect of GABA, holding the chloride channel open longer. Chloride flows into the neuron, the cell hyperpolarizes, and it becomes harder to fire. Scaled across the cortex and brainstem, that widespread inhibition produces sedation, hypnosis, and — at higher concentrations — general anesthesia. Unlike benzodiazepines, at high enough doses propofol can directly activate the receptor even without much ambient GABA, which is part of why it can produce deep anesthesia so reliably.
Because propofol is extremely lipophilic, it crosses the blood-brain barrier almost immediately, which explains the fast onset (roughly one arm-brain circulation time). It is then rapidly redistributed out of the brain into peripheral tissues, which is why a single bolus wears off quickly. This redistribution — not metabolism — drives the rapid wake-up, and it is why propofol has a short context-sensitive half-time even after moderate infusions, making it the sedative of choice when you need frequent neuro exams. Compare that speed with a benzodiazepine in the propofol vs. midazolam comparison.
The hypotension you see minutes after starting propofol is not a side effect layered on top — it is baked into the mechanism. Propofol lowers blood pressure through three converging routes:
| Mechanism | Effect |
|---|---|
| Arterial & venous vasodilation | Reduced systemic vascular resistance and venous return (preload) |
| Direct myocardial depression | Modestly reduced contractility, especially at induction doses |
| Blunted baroreflex | Heart rate does not rise appropriately to defend the falling pressure |
Put those together and you understand why the hypotension is worst in exactly the patients who can least afford it: the hypovolemic, the septic, the elderly, and anyone already on a pressor. In a volume-depleted patient, the loss of venous tone alone can drop the pressure dramatically. This is why induction and up-titration in an unstable patient should be slower and lower, why fluid status matters, and why a norepinephrine drip is so often started or increased in the same breath. Review the pressor side of that equation in the norepinephrine guide and the broader vasopressor guide.
Propofol is not water-soluble, so it is delivered as a 1% oil-in-water emulsion (soybean oil, egg lecithin, glycerol). That vehicle carries consequences that have nothing to do with the GABA receptor:
Calories. The emulsion delivers roughly 1.1 kcal/mL of fat. A patient on a meaningful propofol rate for days is receiving a substantial hidden fat load that dietitians must count against the nutrition plan to avoid overfeeding.
Hypertriglyceridemia. Prolonged or high-dose infusions can raise serum triglycerides, which is itself a risk factor for pancreatitis and is one of the warning flags associated with PRIS. Many units check a triglyceride level after 48–72 hours of continuous propofol.
Infection. The lipid emulsion is an excellent bacterial growth medium. That is why propofol tubing and the vial are changed on a strict schedule (commonly every 12 hours) and strict aseptic technique is non-negotiable.
Allergy history. Formulations have historically raised questions about egg and soy allergy; know your product and your patient's allergy history and escalate any concern to pharmacy.
The hallmark that should stop you is an otherwise unexplained metabolic (lactic) acidosis in a patient on a prolonged, high-dose propofol infusion. Watch for this constellation:
| PRIS warning sign | What you may see |
|---|---|
| Metabolic acidosis | Rising lactate, falling pH with no clear alternative source |
| Cardiac | New arrhythmias, bradycardia, Brugada-like ECG changes, cardiac failure |
| Rhabdomyolysis | Rising CK, myoglobinuria (dark urine), hyperkalemia |
| Renal / metabolic | Acute kidney injury, hyperkalemia, hyperlipidemia |
| Escalating pressor need | Worsening shock that does not fit the primary diagnosis |
The treatment is early recognition and stopping the propofol — switching to an alternative sedative — plus supportive care for the acidosis, hyperkalemia, and cardiac instability. Because the syndrome can be refractory once established, the nurse's real job is upstream: keep the dose as low as effective, flag prolonged high-dose infusions, and connect the dots when a stable patient's lactate and potassium start creeping without an obvious cause. If your patient needs deep sedation for a long time, that is exactly the situation where the team should discuss a propofol-sparing plan — see the wider ICU sedation & analgesia guide and the precedex vs. propofol comparison.
Once you understand the pharmacology, the monitoring plan writes itself. Watch the blood pressure continuously because vasodilation is guaranteed. Track the triglycerides and daily fat calories because of the lipid vehicle. Change tubing on schedule because of infection risk. And keep one eye on the acid-base and CK trend on any patient who has been deep and high-dose for days, because that is where PRIS hides. Pair sedation with adequate analgesia — propofol is a hypnotic, not an analgesic, so a patient in pain may look "undersedated" when they actually need an opioid like fentanyl.
On the CRNA path, propofol is the induction agent you will push thousands of times and the maintenance infusion behind total intravenous anesthesia (TIVA). The receptor pharmacology, the predictable pressure drop, the context-sensitive half-time, and the PRIS ceiling on prolonged dosing are identical concepts in the OR and the ICU. Learning propofol at the mechanism level now means you already understand a huge fraction of your future anesthetic practice.
Propofol potentiates GABA-A to sedate fast and clear fast; that same lipophilic, vasodilating, mitochondria-stressing nature explains the hypotension, the calorie load, and the rare-but-lethal PRIS. Titrate to the lowest effective dose, defend the blood pressure proactively, mind the triglycerides and tubing, and treat an unexplained acidosis on a high, long infusion as PRIS until proven otherwise.
This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.
Get the ICU Notebook
Free investing strategies built for nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.